Kappalightchain抗体;Kappalightchain Antibody—艾普蒂 新品

+ +

•  

   

     Western blot analysis of Kappa light chain expression in human plasma lysate.    

  
  

The kappa light chain antibody is a critical reagent in immunology and clinical diagnostics, specifically targeting the kappa (κ) light chain of immunoglobulins. Antibodies (immunoglobulins) are composed of two heavy chains and two light chains, with light chains existing as either kappa or lambda (λ) types. In humans, approximately 60% of antibodies carry kappa light chains, while 40% have lambda chains. This ratio is often disrupted in clonal B-cell or plasma cell disorders, making kappa light chain antibodies essential for identifying such abnormalities.

In research, these antibodies are widely used in techniques like immunohistochemistry (IHC), flow cytometry, and Western blotting to detect κ light chain expression, aiding in the characterization of B-cell lineages, lymphoid tissues, or plasma cell neoplasms. Clinically, they are pivotal in diagnosing and monitoring conditions like multiple myeloma, lymphoma, or autoimmune diseases. For example, an abnormal κ:λ ratio in serum or urine often indicates monoclonal gammopathies. Additionally, κ-specific antibodies help distinguish between polyclonal (reactive) and monoclonal (neoplastic) proliferations, guiding treatment decisions.

Commercial kappa light chain antibodies are typically monoclonal, ensuring high specificity. Their development and validation have significantly advanced precision in hematopathology and immunology, underscoring their role in both basic science and translational medicine.